UBS adjusted its price target for Oracle, lowering it to $280 from $325, while maintaining a "Buy" rating. This revision from the prominent investment bank suggests a more cautious outlook on Oracle's near-term valuation prospects, despite continued positive sentiment. Oracle's stock closed at $192.59 on January 5, 2026, down 1.59%, and saw a slight gain of 0.41% in pre-market trading on January 6, reaching $193.37.